Solutions
Company
Resources
Publications
Careers
Contact us
Skip to content
New and Noteworthy
Publication summary
Topics
Publications
Real-world evidence
Health equity
Methodology
Non-small cell lung cancer
Clinical research
Machine learning
Multiple myeloma
Clinical decision support
HTA and market access
Metastatic breast cancer
Treatment patterns
Drug discovery
Regulatory
Point of care
Advanced endometrial cancer
Colorectal cancer
Prospective study
Diffuse large B-Cell lymphoma
AP - Blythe Adamson, MPH, PhD
Ovarian cancer
Breast cancer
Acute myeloid leukemia
Patient identification
Trial design
AP - Ivy Altomare, MD
Post marketing requirements
Data science
Research
Melanoma
Practice management
Pancreatic cancer
Site identification
Quality improvement
Chronic lymphocytic leukemia
Comparative effectiveness
Tumor agnostic
Protocol optimization
Data management
EHR-to-EDC
Content type
Publication summary
Press releases
Video
Case study
Clear
Apply filter
Showing 9 of
0
results
A real-world analysis of the relationship between Epstein-Barr Virus positivity and baseline characteristics, treatment patterns and clinical outcomes in diffuse large B-cell lymphoma
ASH Annual Meeting
Publication summary
Publications
Diffuse large B-Cell lymphoma
Design and methodological considerations for real-world data-derived progression-free survival in Multiple Myeloma
ASH Annual Meeting
Publication summary
Publications
Multiple myeloma
The impact of structural racism and social determinants of health on fluorescence in situ hybridization testing among patients with multiple myeloma
ASH Annual Meeting
Publication summary
Publications
Real-world characteristics and survival outcomes of patients with Mantle Cell Lymphoma treated with covalent Bruton's tyrosine kinase inhibitors in first-line
ASH Annual Meeting
Publication summary
Publications
Real-world outcomes of Acute Myeloid Leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2
ASH Annual Meeting
Publication summary
Publications
Treatment patterns and predictors of survival after first line therapy in large B-Cell lymphoma in a real-world US cohort
ASH Annual Meeting
Publication summary
Publications
Evaluating reasons for differences in real-world clinical outcomes among patients with relapsed/refractory Mantle Cell Lymphoma on covalent BTK inhibitors
ASH Annual Meeting
Publication summary
Publications
Mediators of racial/ethnic inequities in clinical trial participation among patients with cancer, 2011-2023
JNCI Cancer Spectrum
Clinical research
Publication summary
Publications
Health equity
Is individual-patient data essential for transportability, or can aggregated data suffice?
ISPOR Europe
Real-world evidence
Publication summary
Publications
View more